248 related articles for article (PubMed ID: 26520661)
1. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
[TBL] [Abstract][Full Text] [Related]
2. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
[TBL] [Abstract][Full Text] [Related]
3. Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Karlov D; Pitushkin D; Vernigora A; Rasskazova E; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2020 Sep; 30(18):127430. PubMed ID: 32736212
[TBL] [Abstract][Full Text] [Related]
4. Effects of adamantane alterations on soluble epoxide hydrolase inhibition potency, physical properties and metabolic stability.
Burmistrov V; Morisseau C; Harris TR; Butov G; Hammock BD
Bioorg Chem; 2018 Feb; 76():510-527. PubMed ID: 29310082
[TBL] [Abstract][Full Text] [Related]
5. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
6. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.
Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649
[TBL] [Abstract][Full Text] [Related]
7. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
[TBL] [Abstract][Full Text] [Related]
8. Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.
Kim IH; Heirtzler FR; Morisseau C; Nishi K; Tsai HJ; Hammock BD
J Med Chem; 2005 May; 48(10):3621-9. PubMed ID: 15887969
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
Hwang SH; Morisseau C; Do Z; Hammock BD
Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285
[TBL] [Abstract][Full Text] [Related]
10. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
Codony S; Pujol E; Pizarro J; Feixas F; Valverde E; Loza MI; Brea JM; Saez E; Oyarzabal J; Pineda-Lucena A; Pérez B; Pérez C; Rodríguez-Franco MI; Leiva R; Osuna S; Morisseau C; Hammock BD; Vázquez-Carrera M; Vázquez S
J Med Chem; 2020 Sep; 63(17):9237-9257. PubMed ID: 32787085
[No Abstract] [Full Text] [Related]
11. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors.
Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD
Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425
[TBL] [Abstract][Full Text] [Related]
12. 1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.
Kim IH; Tsai HJ; Nishi K; Kasagami T; Morisseau C; Hammock BD
J Med Chem; 2007 Oct; 50(21):5217-26. PubMed ID: 17894481
[TBL] [Abstract][Full Text] [Related]
13. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
Morisseau C; Goodrow MH; Newman JW; Wheelock CE; Dowdy DL; Hammock BD
Biochem Pharmacol; 2002 May; 63(9):1599-608. PubMed ID: 12007563
[TBL] [Abstract][Full Text] [Related]
14. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
Anandan SK; Webb HK; Do ZN; Gless RD
Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
[TBL] [Abstract][Full Text] [Related]
15. Insight into the binding modes and inhibition mechanisms of adamantyl-based 1,3-disubstituted urea inhibitors in the active site of the human soluble epoxide hydrolase.
Chen H; Zhang Y; Ye C; Feng TT; Han JG
J Biomol Struct Dyn; 2014; 32(8):1231-47. PubMed ID: 23815795
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
Kim IH; Morisseau C; Watanabe T; Hammock BD
J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.
North EJ; Scherman MS; Bruhn DF; Scarborough JS; Maddox MM; Jones V; Grzegorzewicz A; Yang L; Hess T; Morisseau C; Jackson M; McNeil MR; Lee RE
Bioorg Med Chem; 2013 May; 21(9):2587-99. PubMed ID: 23498915
[TBL] [Abstract][Full Text] [Related]
20. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
